VNQ vs SCHH: returns, risk and drawdowns compared
Vanguard Real Estate ETF against Schwab U.S. REIT ETF, over the same 6 years (July 2020 to October 2026) with dividends reinvested.
Data updated October 2026
VNQ
Vanguard Real Estate ETF
10,000 became
14,905
- A year on average
- +6.5%
- Annual volatility
- 18.3%
- Deepest fall
- −32.7%
- Worst month
- −12.9%
SCHH
Schwab U.S. REIT ETF
10,000 became
15,062
- A year on average
- +6.7%
- Annual volatility
- 17.9%
- Deepest fall
- −31.5%
- Worst month
- −12.6%
SCHH came out ahead by 0.2 percentage points a year from July 2020 to October 2026. VNQ swung more (18.3% against 17.9% a year). The correlation of monthly returns was 1.00: they moved almost in lockstep.
Growth of 10,000: VNQ vs SCHH
Who was ahead, and when
The gap between the two over the previous three years, at each month-end. Above zero VNQ had returned more, below zero SCHH. VNQ was ahead in 32% of the 41 three-year periods.
Annualised 3-year return of VNQ minus that of SCHH, in percentage points a year.
Falls from the previous high
Month-end values. Deepest fall: VNQ −32.7%, SCHH −31.5%.
All the figures
| VNQ | SCHH | |
|---|---|---|
| Annual return (CAGR) | +6.5% | +6.7% |
| Total return | +49% | +51% |
| Annual volatility | 18.3% | 17.9% |
| Deepest fall (month-end) | −32.7% | −31.5% |
| Worst month | −12.9% | −12.6% |
| Best month | +12.1% | +11.6% |
| Positive months | 61% | 59% |
| Best year | 2021: +40.5% | 2021: +39.9% |
| Worst year | 2022: −26.2% | 2022: −25.0% |
| 1-year return | +4.0% | +7.1% |
| 5 years, a year | +0.7% | +1.4% |
| 10 years, a year | — | +3.1% |
| Trading currency | USD | USD |
First nine rows: the same 76 months for both funds. Trailing returns: to each fund’s last close.
Year by year
Full calendar years both funds were trading. The higher of the two each year is in bold.
Holding both: half VNQ, half SCHH
| VNQ alone | SCHH alone | 50/50 | |
|---|---|---|---|
| A year on average | +6.5% | +6.7% | +6.6% |
| Annual volatility | 18.3% | 17.9% | 18.1% |
| Deepest fall (month-end) | −32.7% | −31.5% | −32.1% |
| Worst month | −12.9% | −12.6% | −12.7% |
With a correlation of 1.00 the mix behaved almost like either fund alone: its volatility of 18.1% sits between the two. Rebalanced to 50/50 every month, before costs.
Questions
Which has returned more, VNQ or SCHH?
From July 2020 to October 2026, VNQ returned +6.5% a year and SCHH +6.7% a year, with dividends reinvested. Over rolling 3-year periods VNQ did better in 32% of cases. Past returns do not predict future returns.
Which is riskier, VNQ or SCHH?
Over the same months annual volatility was 18.3% for VNQ and 17.9% for SCHH; the deepest fall from a month-end high was 32.7% and 31.5%, and the worst single month −12.9% and −12.6%.
How correlated are VNQ and SCHH?
The correlation of their monthly returns was 1.00: they moved almost in lockstep. Holding both adds little diversification compared with holding one.
What about holding both VNQ and SCHH?
Half in each, rebalanced every month, returned +6.6% a year over the same period, with 18.1% annual volatility and a deepest month-end fall of 32.1%.
More comparisons
- VNQ — Vanguard Real Estate ETFReturns, drawdowns and risk
- SCHH — Schwab U.S. REIT ETFReturns, drawdowns and risk
- VNQ vs IYR
- VNQ vs XLRE
- SPY vs VNQ
- SCHH vs IYR
- SCHH vs XLRE
- What a crisis would do to your portfolioYour own scenarios, holding by holding
- Portfolio stress testing software comparedFeatures and prices side by side
How the figures are calculated
Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.
The comparison uses only the months in which both funds have prices, so the figures cover the same period even when one fund is older.
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.